Lexeo Therapeutics Spotlights New AAV Manufacturing Data at ASGCT Meeting

Lexeo Therapeutics shares are trading higher after the company announced new data supporting its AAV manufacturing approach, which will be presented at the annual ASGCT meeting, highlighting advancements in high-yield and scalable production capabilities.